Analysts predict surge in ‘blockbuster drugs’ entering the market in 2015Over the next twelve months there will be 11 “blockbuster” drugs entering the market, according to business intelligence company Thomson Reuters.…
FDA approves cholic acid for rare bile acid synthesis disordersCholic acid, a drug used to treat bile acid synthesis disorders and peroxisomal disorders, has been approved by the US Food and Drug Administration.…
FDA takes legal action against compounding pharmacyThe US Food and Drug Administration has taken legal action to prevent a compounding pharmacy from manufacturing or holding sterile drugs.…
Large proportion of stalled drug trial data is not being published, study finds A vast amount of drug development data are being lost through the failure to publish the results of a high proportion of trials, particularly of drugs that did not go on to be approved, a study suggests. …
US FDA approves drug that prolongs survival in rare paediatric cancer The US Food and Drug Administration has approved dinutuximab as part of first-line therapy for a rare childhood cancer, neuroblastoma. …
FDA grants priority approval for new antifungalIsavuconazonium sulfate, an antifungal developed by Astellas, has been given priority approval by the US Food and Drug Administration to treat serious infections.…
How the pharmaceutical industry is contributing to antimicrobial resistance Through poor practices, the pharmaceutical industry is adding to the problem of antimicrobial resistance instead of helping to solve it.…
US FDA launches app that alerts public about drug shortagesA mobile app that allows users to track drug shortages in the United States has been launched by the US Food and Drug Administration.…
US FDA approves antibiotic combination with new beta-lactamase inhibitor The US Food and Drug Administration has approved a new intravenous antibacterial product, Avycaz, which contains ceftazidime and a new beta-lactamase inhibitor, avibactam.…
FDA fast tracks approval of panobinostat for multiple myeloma The US Food and Drug Administration has fast-tracked the approval of the first histone deacetylase inhibitor to treat patients with multiple myeloma.…
